Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
105
mi
from 91732
La Mesa, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
105
mi
from 91732
La Mesa, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
379
mi
from 91732
Lincoln, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
379
mi
from 91732
Lincoln, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
22
mi
from 91732
N. Hollywood, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
22
mi
from 91732
N. Hollywood, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
31
mi
from 91732
Newport Beach, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
31
mi
from 91732
Newport Beach, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
27
mi
from 91732
Norco, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
27
mi
from 91732
Norco, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
26
mi
from 91732
Oakwood, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
26
mi
from 91732
Oakwood, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
73
mi
from 91732
Oceanside, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
73
mi
from 91732
Oceanside, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
21
mi
from 91732
Orange, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
105
mi
from 91732
San Diego, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
24
mi
from 91732
Santa Ana, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
24
mi
from 91732
Santa Ana, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
804
mi
from 91732
Colorado Springs, CO
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
804
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
817
mi
from 91732
Denver, CO
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2140
mi
from 91732
Bradenton, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2140
mi
from 91732
Bradenton, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2144
mi
from 91732
Brandon, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2144
mi
from 91732
Brandon, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2197
mi
from 91732
Brookville, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2197
mi
from 91732
Brookville, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2078
mi
from 91732
Chiefland, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2078
mi
from 91732
Chiefland, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2107
mi
from 91732
Crystal River, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2107
mi
from 91732
Crystal River, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from 91732
DeLand, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from 91732
DeLand, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2204
mi
from 91732
Fort Myers, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2204
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2315
mi
from 91732
Hialeah, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2315
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2122
mi
from 91732
Inverness, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2122
mi
from 91732
Inverness, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2295
mi
from 91732
Jupiter, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2295
mi
from 91732
Jupiter, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2197
mi
from 91732
Kissimee, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2197
mi
from 91732
Kissimee, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2183
mi
from 91732
Maitland, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2183
mi
from 91732
Maitland, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2314
mi
from 91732
Miramar, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2314
mi
from 91732
Miramar, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2220
mi
from 91732
Naples, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2220
mi
from 91732
Naples, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2128
mi
from 91732
Ocala, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2128
mi
from 91732
Ocala, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2122
mi
from 91732
Oldsmar, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2122
mi
from 91732
Oldsmar, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2182
mi
from 91732
Orlando, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2182
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2125
mi
from 91732
Pinellas Park, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2125
mi
from 91732
Pinellas Park, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2311
mi
from 91732
Plantation, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2311
mi
from 91732
Plantation, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2191
mi
from 91732
Port Orange, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2191
mi
from 91732
Port Orange, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2148
mi
from 91732
Sarasota, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2148
mi
from 91732
Sarasota, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2130
mi
from 91732
St. Petersburg, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2130
mi
from 91732
St. Petersburg, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1904
mi
from 91732
Austell, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1904
mi
from 91732
Austell, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1902
mi
from 91732
Columbus, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1902
mi
from 91732
Columbus, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1930
mi
from 91732
Duluth, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1930
mi
from 91732
Duluth, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1908
mi
from 91732
Marietta, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1908
mi
from 91732
Marietta, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1900
mi
from 91732
Newnan, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1900
mi
from 91732
Newnan, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1939
mi
from 91732
Snellville, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1939
mi
from 91732
Snellville, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
1907
mi
from 91732
Woodstock, GA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
1907
mi
from 91732
Woodstock, GA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
664
mi
from 91732
Meridian, ID
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
664
mi
from 91732
Meridian, ID
Click here to add this to my saved trials